QuantaMatrix

QuantaMatrix (QM) is an in vitro diagnostics company specializing in the discovery, development and commercialization of fully integrated solutions within the sepsis value chain, with the mission to help healthcare professionals to provide better careand therapy management for sepsis patients.

Established in 2010 as a spin-off from Biophotonics and Nano Engineering Lab(BiNEL) in the College of Engineering Department at Seoul National University, QuantaMatrix is operating in Korea and France and has successfully established a network of distribution all over Europe and Middle East.

QuantaMatrix’s direct Rapid Antimicrobial Susceptibility Testing system (dRAST™) brings rapid phenotypic MIC results in as low as 4 hours for Gram-negative and Gram-positive bacteria on positive blood culture samples, providing optimal antimicrobial therapies and allowing patients to be treated by up to 2 days faster than conventional methods.

For further information, please visit www.quantamatrix.com or YouTube Channel ‘QuantaMatrix Media’.